Beta-blockers and breastfeeding: a real-life prospective study
European Journal of Clinical Pharmacology · 2024
DOI: 10.1007/s00228-024-03753-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Romane Freppel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Pharmacovigilance Et de Pharmacoépidémiologie, Service de Pharmacologie Médicale, CHU de Lille, Lille, France. romane.freppel@chu-dijon.fr. Hauptthemen laut MEDLINE: Breast Feeding, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Themen: Hebammenwesen und Geburtshilfe, Stillen
Abstract (Originalsprache)
PURPOSE: At Lille University Hospital, a pregnancy heart team including cardiologists, obstetricians, pediatricians, anesthetists, geneticists, and pharmacologists discusses about treatment compatibility taken during breastfeeding in pregnant women (or those wishing to be pregnant) with complex cardiovascular pathologies. Beta-blockers are among the drug most often used in these patients, and data are missing or suggest a risk to the breastfed child. The aim of this study was to evaluate the proportion of women treated with beta-blockers, identified during the multidisciplinary meeting, who breastfed and to monitor adverse effects (AEs) in newborns. METHODS: A prospective descriptive study was conducted from 1 December 2017 to 1 December 2021. All pregnant patients followed up by the pregnancy heart team in Lille University Hospital, treated with beta-blockers and who gave birth, were contacted as part of the pharmacovigilance follow-up. RESULTS: The proportion of women treated with beta-blockers intending to breastfeed was 69.8%. Among the 53 women interviewed, 49% did not breastfeed, including 10 because of the theoretical incompatibility of their beta-blocker with breastfeeding. Among the 27 women who breastfed, 30% breastfed while treated with a theoretically incompatible beta-blocker; 56% was changed from their initial beta-blocker to allow safe breastfeeding. No serious AE was observed. CONCLUSION: To our knowledge, our study is the largest series of patients treated with beta-blockers during breastfeeding. Taking a treatment can be an obstacle to breastfeeding, but for the particular case of beta-blockers, even if the available data are few and sometimes worrying, the data from this study are reassuring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Pharmacovigilance Et de Pharmacoépidémiologie, Service de Pharmacologie Médicale, CHU de Lille, Lille, France. romane.freppel@chu-dijon.fr.
- Centre de Pharmacovigilance Et de Pharmacoépidémiologie, Service de Pharmacologie Médicale, CHU de Lille, Lille, France.
- Service d'explorations Fonctionnelles Cardiovasculaires, Institut Cœur Poumon, CHU Lille, Lille, France.
- Department of Obstetrics, CHU Lille, 59000, Lille, France.
- Service de Cardiologie Pédiatrique et Congénitale, CHU Lille, Lille, France.
- ULR2694 (METRICS : Évaluation des Technologies de Santé et des Pratiques Médicales), Univ. Lille, CHU Lille, 59000, Lille, France.
Zitieren
APA
Freppel, R., Gaboriau, L., Richardson, M., Ould, Y., Domanski, O., Pinçon, C., Ghesquière, L., & Gautier, S. (2024). Beta-blockers and breastfeeding: a real-life prospective study. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03753-y
Vancouver
Freppel R, Gaboriau L, Richardson M, Ould Y, Domanski O, Pinçon C, et al. Beta-blockers and breastfeeding: a real-life prospective study. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03753-y
BibTeX
@article{Freppel2024,
author = {Freppel, Romane and Gaboriau, Louise and Richardson, Marjorie and Ould, Yasmine and Domanski, Olivia and Pinçon, Claire and Ghesquière, Louise and Gautier, Sophie},
title = {Beta-blockers and breastfeeding: a real-life prospective study},
journal = {European Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1007/s00228-024-03753-y}
}
EUVIMED